Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1995-05-30
1998-06-16
McKane, Joseph
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514423, 514424, 514425, 514426, 514428, 514429, A61K 3140, C07D20708
Patent
active
057671443
ABSTRACT:
A compound of the formula (I): ##STR1## or a pharmaceutically acceptable salt thereof is disclosed, as well as processes for and intermediates in the preparation thereof, and a method of antagonizing endothelin.
REFERENCES:
patent: 3342833 (1967-09-01), Fremery
patent: 4340715 (1982-07-01), Grounder et al.
Bhagwat, S., "Synthesis of Enantiomerically Pure Pyrrolidinones as Endothelin Receptor Antagonists", Tetrahedron Letters, 37(27):4627-4630, 1984.
Winn, et al., 2,4-Diarylpyrrolidine-3-carboxylic Acids-Potent ET.sub.A Selective Endothelin Receptor Antagonists. 1. Discovery of A-127722, 1986.
Tsuge, et al. Chemistry Letters 801-804 (1984).
Tsuge, et al. Bull. Chem. Soc. Jpn 59 2537 (1986).
Boyd Steven A.
Hutchins Charles W.
Jae Hwan-Soo
Kester Jeffrey A.
Sorensen Bryan K.
Abbott Laboratories
Crowley Steven R.
McKane Joseph
Ward Michael J.
LandOfFree
Endothelin antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Endothelin antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Endothelin antagonists will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1726438